These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26161019)

  • 1. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
    Min HK; Lee B; Kwok SK; Ju JH; Kim WU; Park YM; Park SH
    Korean J Intern Med; 2015 Jul; 30(4):521-30. PubMed ID: 26161019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.
    Jung JW; Song WJ; Kim YS; Joo KW; Lee KW; Kim SH; Park HW; Chang YS; Cho SH; Min KU; Kang HR
    Nephrol Dial Transplant; 2011 Nov; 26(11):3567-72. PubMed ID: 21393610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allopurinol hypersensitivity syndrome. A report of two cases].
    Rodríguez-Arámbula A; Arenas-Velázquez E; Castanedo-Cázares JP; Hernández-Blanco D; Oros-Ovalle C; Torres-Álvarez B
    Rev Med Inst Mex Seguro Soc; 2016; 54(2):261-4. PubMed ID: 26960055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol Use and Risk of Fatal Hypersensitivity Reactions: A Nationwide Population-Based Study in Taiwan.
    Yang CY; Chen CH; Deng ST; Huang CS; Lin YJ; Chen YJ; Wu CY; Hung SI; Chung WH
    JAMA Intern Med; 2015 Sep; 175(9):1550-7. PubMed ID: 26193384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to prevent allopurinol hypersensitivity reactions?
    Stamp LK; Barclay ML
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i35-i41. PubMed ID: 29272508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
    Huang YC; Shih PY; Chin SY; Chiang YY
    J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
    [No Abstract]   [Full Text] [Related]  

  • 8. Pustular drug hypersensitivity syndrome due to allopurinol.
    Ben Salem C; Saidi W; Larif S; Fathallah N; Slim R; Hmouda H
    Indian J Pharmacol; 2015; 47(1):123-4. PubMed ID: 25821326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol Induced DRESS Syndrome.
    Pawar P; Gupta VA; Karnik ND; Vaidya M; Khopkar U
    J Assoc Physicians India; 2014 Nov; 62(11):63-5. PubMed ID: 26281488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N; Stamp L
    Semin Dial; 2007; 20(5):391-5. PubMed ID: 17897242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fatal liver necrosis due to allopurinol].
    Pereira S; Almeida J; Silva AO; Quintas M; Candeias O; Freitas F
    Acta Med Port; 1998 Dec; 11(12):1141-4. PubMed ID: 10192993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA-B58.01 and allopurinol hypersensitivity renal vasculitis in a Chinese patient].
    Mariette F; Scarfoglière V; Giot M; Basire A; Rouby F; Daniel L; Jourde-Chiche N
    Rev Med Interne; 2022 Jul; 43(7):436-439. PubMed ID: 35606203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol hypersensitivity syndrome: a review.
    Arellano F; Sacristán JA
    Ann Pharmacother; 1993 Mar; 27(3):337-43. PubMed ID: 8453174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allopurinol-induced hypersensitivity syndrome].
    Kinyó A; Lakatos A; Varga A; Gyulai R; Varga E; Bata-Csörgő Z; Kemény L
    Orv Hetil; 2012 Apr; 153(15):586-91. PubMed ID: 22472359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome associated with reactivation of Epstein-Barr virus leading to secondary hemophagocytic lymphohistiocytosis in an HLA-B*5801-negative patient.
    Su T; Xiong W; Xu Y; Lu Y
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):545-548. PubMed ID: 34219434
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DR9 and DR14 are associated with the allopurinol-induced hypersensitivity in hematologic malignancy.
    Jung JW; Kim JY; Yoon SS; Cho SH; Park SY; Kang HR
    Tohoku J Exp Med; 2014 Jun; 233(2):95-102. PubMed ID: 24858023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allopurinol-induced DRESS syndrome: Drug Reaction with Eosynophilia and Systemic Symptoms (DRESS)].
    Zemmez Y; Hjira N
    Pan Afr Med J; 2018; 30():120. PubMed ID: 30364443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life Threatening, Allopurinol-related Dress Syndrome as a Rare Cause of Fever of Unknown Origin.
    Civardi G; Zanlari L; Bassi E; Zangrandi A; Maria Cesinaro A; Nosseir S; De Maria N
    Intern Med; 2015; 54(16):2073-7. PubMed ID: 26278306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.